Annual Drug Patent Expirations for LESCOL+XL Lescol Xl is a drug marketed by Novartis and is included in one NDA. It is available from two suppliers. There is one patent…
The post New patent expiration for Novartis drug LESCOL XL appeared first on Drug…
New patent expiration for Novartis drug LESCOL XL Read Post »
Annual Drug Patent Expirations for ADVAIR+HFA Advair Hfa is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Glaxo Grp drug ADVAIR HFA appeared first on DrugPa…
New patent expiration for Glaxo Grp drug ADVAIR HFA Read Post »
Annual Drug Patent Expirations for FLOVENT+HFA Flovent Hfa is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from three suppliers. There are…
The post New patent expiration for Glaxo Grp drug FLOVENT HFA appeared first on …
New patent expiration for Glaxo Grp drug FLOVENT HFA Read Post »
Annual Drug Patent Expirations for VENTOLIN+HFA Ventolin Hfa is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from ten suppliers. There are three patents…
The post New patent expiration for Glaxosmithkline drug VENTOLIN…
New patent expiration for Glaxosmithkline drug VENTOLIN HFA Read Post »
Annual Drug Patent Expirations for PICATO Picato is a drug marketed by Leo Labs and is included in one NDA. It is available from one supplier. There are thirteen patents…
The post New patent expiration for Leo Labs drug PICATO appeared first on DrugPat…
BYDUREON PEN (exenatide synthetic) Astrazeneca ab Patent: 9,198,925 Expiration: Oct 4, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations …
Drug Patent Expirations for the Week of October 4, 2020 Read Post »
Annual Drug Patent Expirations for XIGDUO+XR Xigduo Xr is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are eight…
The post New patent expiration for Astrazeneca Ab drug XIGDUO XR appeared first …
New patent expiration for Astrazeneca Ab drug XIGDUO XR Read Post »
Annual Drug Patent Expirations for FARXIGA Farxiga is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from three suppliers. There are eighteen patents…
The post New patent expiration for Astrazeneca Ab drug FARXIGA appeare…
New patent expiration for Astrazeneca Ab drug FARXIGA Read Post »
Annual Drug Patent Expirations for QTERN Qtern is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are twelve patents…
The post New patent expiration for Astrazeneca Ab drug QTERN appeared first on…
New patent expiration for Astrazeneca Ab drug QTERN Read Post »
BYDUREON (exenatide synthetic) Astrazeneca ab Patent: 9,198,925 Expiration: Oct 4, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Dr…
Drug Patent Expirations for the Week of October 4, 2020 Read Post »